The side effect profiles at equivalent escalation points are different
It occupies a scientifically legitimate space between those extremes: a peptide with a plausible endogenous origin, a well-characterized set of molecular targets, and an unusually consistent preclinical record across diverse injury models and species
The targets reflect where the underlying peptides have been studied: tendons and ligaments, muscle strains, slow-healing wounds, and the gut lining
Offered in a 5mg vial of lyophilized powder, this peptide functions as a NNMT inhibitor, playing a vital role in metabolic regulation and fat metabolism support
BPC-157 has demonstrated the ability to accelerate healing in Achilles tendon ruptures, patellar tendon injuries, and medial collateral ligament (MCL) damage